Mapping of the human adenosine A(2a) receptor gene: Relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region

Human Genetics

Volumn 99, Issue 3, 1997, Pages 326-328

  Deckert, Jürgen ^a   Nöthen, Markus M ^a   Bryant, Stephan P ^b   Schuffenhauer, Simone ^c   Schofield, Peter R ^d   Spurr, Nigel K ^b   Propping, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR;

ARTICLE; CHROMOSOME 22Q; DISEASE PREDISPOSITION; FAMILY STUDY; GENE DELETION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

ABNORMALITIES, MULTIPLE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SCHIZOPHRENIA; SYNDROME;

EID: 1842326196     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050366     Document Type: Article

References (20)

1. 6-(2-2-Diphenylethyl)-adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem 30:1709-1711
2. Buetow KH, Weber JL, Ludwigsten S, Scherpbier-Heddema T, Duyk GM, Scheffield VC, Wang Z, Murray JC (1994) Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet 6:391-393
3. Coon HS, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, Waldo M, Freedman R, Byerley W (1994) Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Hum Genet 54:72-79
4. Cottingham RW, Idury RM, Schaffer AA (1993) Faster sequential genetic linkage computations. Am J Hum Genet 53:252-263
5. Ferre S, O'Connor WT, Sbaprud P, Ungerstedt U, Fuxe K (1994) Antagonistic interaction between adenosine A2a and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63:765-773
6. Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective coexpression with D2 dopamine receptors in rat striatum. Mol Brain Res 14:186-195
7. Green P, Falls K, Crooks S (1989) Documentation for CRI-MAP, Version 2.4. Available from P. Green, Genetics Department, Washington University School of Medicine, St Louis, MO
8. Halford E, Lindsay E, Nayudu M, Caroy AH, Baldini A, Scambler B (1993) Low-copy-number repeat sequences flank the Di-George/velo-cardio-facial syndrome loci at 22q11. Hum Mol Genet 2:191-196
9. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Cos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen HM, Childs B, Kazazian HH, Kucherlapati R, Antonorakis SE, Pulver AE, Housman DE (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92:7612-7616
10. Kruglyak L, Lander E (1995) High resolution genetic mapping of complex traits. Am J Hum Genet 56:1212-1223
11. Lathrop GM, Lalouel JM (1984) Easy calculation of lod scores and genetic risks on small computers. Am J Hum Genet 36:460-465
12. Le F, Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PF (1996) Characterization and chromosomal localization of the human A2a adenosine receptor subtype gene: ADORA2A. Biochem Biophys Res Commun 223:461-467
13. Lucas PB, Pickar D, Kelsoe J, Rapaport M, Pato C, Hommer D (1990) Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 28:35-40
14. MacCollin M, Peterfreund R, MacDonald M, Fink JS, Gusella J (1994) Mapping of human A2a adenosine receptor (ADORA2) to chromosome 22. Genomics 20:332-333
15. Mulder MP, Wilke M, Langeveld A, Wilming LG, Hagemeijer A, vanDrunen E, Zwarthoff EC, Riegemann PHJ, Deelen WH, Ouweland AMW van den, Halley DJJ, Meijers C (1995) Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker D22S183. Hum Genet 96: 133-141
16. Propping P, Nöthen MM (1995) Schizophrenia: genetic tools for unraveling the nature of a complex disorder. Proc Natl Acad Sci USA 92:7607-7608
17. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D, Ott J, Lamacz M, Liang K-Y, Hanfelt J, Ullrich G, De-Marchi N, Ramu E, McHugh PR, Adler L, Thomas M, Carpenter WT, Manschreck T, Gordon CT, Kimberland M, Babb R, Puck J, Childs B (1994) Sequential strategy to identify a susceptibility gene on chromosome 22q12-q13.1: part 1. Am J Med Genet 54:36-43
18. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, Lichtermann D, Minges J, Bondy B, Ackenheil M, Altmark D, Hasib D, Gur E, Ebstein RP, Wildenauer DB (1995) Potential linkage for schizophrenia on chromosome 22q12-13: a replication study. Am J Med Genet 60:436-443
19. Vallada HP, Gill M, Sham P, Lim LCC, Nanko S, Asherson P, Murray RM, McGuffin P, Owen M, Collier D (1995) Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet 60:139-146
20. Wilson DI, Burn J, Scambler P, Goodship J (1993) DiGeorge syndrome: part of CATCH 22. J Med Genet 30:852-856